Cargando…

The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data

BACKGROUND: A variety of psychiatric syndromes are associated with NMDAR autoantibodies; however, their clinical relevance when only present in the serum is unclear. We explored whether patients with CSF NMDAR autoantibodies could be distinguished from patients with serum-only NMDAR autoantibodies....

Descripción completa

Detalles Bibliográficos
Autores principales: Blackman, Graham, Lim, Mao Fong, Pollak, Thomas, Al-Diwani, Adam, Symmonds, Mkael, Mazumder, Asif, Carter, Ben, Irani, Sarosh, David, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467941/
https://www.ncbi.nlm.nih.gov/pubmed/35790561
http://dx.doi.org/10.1007/s00415-022-11224-6
_version_ 1784788303404335104
author Blackman, Graham
Lim, Mao Fong
Pollak, Thomas
Al-Diwani, Adam
Symmonds, Mkael
Mazumder, Asif
Carter, Ben
Irani, Sarosh
David, Anthony
author_facet Blackman, Graham
Lim, Mao Fong
Pollak, Thomas
Al-Diwani, Adam
Symmonds, Mkael
Mazumder, Asif
Carter, Ben
Irani, Sarosh
David, Anthony
author_sort Blackman, Graham
collection PubMed
description BACKGROUND: A variety of psychiatric syndromes are associated with NMDAR autoantibodies; however, their clinical relevance when only present in the serum is unclear. We explored whether patients with CSF NMDAR autoantibodies could be distinguished from patients with serum-only NMDAR autoantibodies. METHODS: The electronic databases MEDLINE, EMBASE, PubMed, and PsycINFO were searched. Articles reporting adult patients with isolated psychiatric features and positive for NMDAR autoantibodies with relevant investigations were included. Patient level meta-analysis compared patients positive for CSF NMDAR autoantibodies with patients positive for serum NMDAR autoantibodies, but negative for CSF NMDAR autoantibodies. Dichotomous data were analysed using crude odds ratios (OR), whilst continuous data were analysed using Mann–Whitney Test (U). The protocol was prospectively registered (CRD42018082210). RESULTS: Of 4413 publications, 42 were included, reporting 79 patients. Median age was 34 years (IQR 19 years); 56% (45/79) were female and 24% (16/68) had a tumour. In total, 41 patients were positive for CSF autoantibodies and 20 were positive for serum-only autoantibodies. Patients with CSF autoantibodies were significantly more likely to be female (p < 0.001) and have a rapid (< 3 month) onset of symptoms (p = 0.02) than patients with serum-only autoantibodies. They were also more likely to present with psychosis (p < 0.001), exhibit EEG (p = 0.006), MRI (p = 0.002), and CSF (p = 0.001) abnormalities, but less likely to present with insomnia (p = 0.04). CONCLUSIONS: Patients with an isolated psychiatric syndrome with CSF NMDAR autoantibodies can potentially be distinguished from those with serum-only NMDAR autoantibodies based on clinicodemographic and investigation findings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11224-6.
format Online
Article
Text
id pubmed-9467941
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94679412022-09-14 The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data Blackman, Graham Lim, Mao Fong Pollak, Thomas Al-Diwani, Adam Symmonds, Mkael Mazumder, Asif Carter, Ben Irani, Sarosh David, Anthony J Neurol Review BACKGROUND: A variety of psychiatric syndromes are associated with NMDAR autoantibodies; however, their clinical relevance when only present in the serum is unclear. We explored whether patients with CSF NMDAR autoantibodies could be distinguished from patients with serum-only NMDAR autoantibodies. METHODS: The electronic databases MEDLINE, EMBASE, PubMed, and PsycINFO were searched. Articles reporting adult patients with isolated psychiatric features and positive for NMDAR autoantibodies with relevant investigations were included. Patient level meta-analysis compared patients positive for CSF NMDAR autoantibodies with patients positive for serum NMDAR autoantibodies, but negative for CSF NMDAR autoantibodies. Dichotomous data were analysed using crude odds ratios (OR), whilst continuous data were analysed using Mann–Whitney Test (U). The protocol was prospectively registered (CRD42018082210). RESULTS: Of 4413 publications, 42 were included, reporting 79 patients. Median age was 34 years (IQR 19 years); 56% (45/79) were female and 24% (16/68) had a tumour. In total, 41 patients were positive for CSF autoantibodies and 20 were positive for serum-only autoantibodies. Patients with CSF autoantibodies were significantly more likely to be female (p < 0.001) and have a rapid (< 3 month) onset of symptoms (p = 0.02) than patients with serum-only autoantibodies. They were also more likely to present with psychosis (p < 0.001), exhibit EEG (p = 0.006), MRI (p = 0.002), and CSF (p = 0.001) abnormalities, but less likely to present with insomnia (p = 0.04). CONCLUSIONS: Patients with an isolated psychiatric syndrome with CSF NMDAR autoantibodies can potentially be distinguished from those with serum-only NMDAR autoantibodies based on clinicodemographic and investigation findings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11224-6. Springer Berlin Heidelberg 2022-07-05 2022 /pmc/articles/PMC9467941/ /pubmed/35790561 http://dx.doi.org/10.1007/s00415-022-11224-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Blackman, Graham
Lim, Mao Fong
Pollak, Thomas
Al-Diwani, Adam
Symmonds, Mkael
Mazumder, Asif
Carter, Ben
Irani, Sarosh
David, Anthony
The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
title The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
title_full The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
title_fullStr The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
title_full_unstemmed The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
title_short The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
title_sort clinical relevance of serum versus csf nmdar autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467941/
https://www.ncbi.nlm.nih.gov/pubmed/35790561
http://dx.doi.org/10.1007/s00415-022-11224-6
work_keys_str_mv AT blackmangraham theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT limmaofong theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT pollakthomas theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT aldiwaniadam theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT symmondsmkael theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT mazumderasif theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT carterben theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT iranisarosh theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT davidanthony theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT blackmangraham clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT limmaofong clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT pollakthomas clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT aldiwaniadam clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT symmondsmkael clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT mazumderasif clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT carterben clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT iranisarosh clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata
AT davidanthony clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata